Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Testosterone Enanthate Conversion Guidelines

Dosage Conversion

  • The recommended equivalent dosage when converting from Xyosted to testosterone 100mg is 100mg of testosterone enanthate weekly, providing similar therapeutic levels to 100mg of testosterone, according to the American Gastroenterological Association 1, 2
  • Testosterone enanthate is typically administered at doses of 100-200mg every 2 weeks or 50-100mg weekly to maintain therapeutic testosterone levels, as suggested by the American Gastroenterological Association 1
  • For patients previously on 100mg testosterone, a direct 1:1 conversion to 100mg of testosterone enanthate weekly is appropriate to maintain similar serum testosterone levels, based on guidelines from the American Gastroenterological Association 2

Monitoring and Safety

  • Testosterone levels should be measured 2-3 months after initiating therapy or changing doses, with a target of mid-normal values, as recommended by the Endocrine Society 3
  • For injectable testosterone formulations, levels should be checked midway between injections, targeting mid-normal values, according to the American Gastroenterological Association and the Endocrine Society 1, 3
  • Once stable levels are achieved, monitoring every 6-12 months is typically sufficient, as suggested by the Endocrine Society 3
  • There is evidence suggesting injectable testosterone may be associated with greater cardiovascular risk compared to transdermal preparations, possibly due to fluctuating testosterone levels, as noted by the American Gastroenterological Association 1
  • Monitor for potential side effects including erythrocytosis, which occurs more frequently with injectable testosterone formulations, as recommended by the Endocrine Society 3
  • Consider cardiovascular risk factors before initiating therapy, as testosterone administration may potentially increase cardiovascular events in high-risk patients, according to the American Gastroenterological Association and the Endocrine Society 1, 3

REFERENCES

3

Testosterone Replacement Therapy Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025